#United States #New York #Securities Fraud #Lufax Holding #SueWallSt

Investigation of Lufax Holding Ltd's Securities Fraud Allegations

In a troubling development for investors, Lufax Holding Ltd (NYSE: LU) is facing serious allegations regarding inadequate disclosures in its 2022 and 2023 Annual Reports. As reported by SueWallSt, the scrutiny of these reports reveals that shareholders who suffered losses may have grounds to lead a class action lawsuit against the company. The situation has escalated following a significant drop in the company's stock price after a corrective disclosure on January 27, 2025, sparking concerns among impacted investors.

Lufax's Risk Disclosures Under Examination

The legal investigation centers on whether Lufax's risk disclosures were sufficient or misleading. Both annual reports included general statements indicating that internal controls might not effectively prevent or detect misstatements. However, the lawsuit contends that the reality within the company was much graver, suggesting that these internal controls were already failing when the disclosures were made. Consequently, the allegations raise critical questions about the integrity of Lufax’s financial reporting and the honesty of its presentations to investors.

Declining Stock Price and Investor Losses

Post the corrective actions on January 27, 2025, Lufax ADS (American Depository Shares) holders experienced a sharp decline in value, losing approximately $0.63 per share over three trading sessions. This translates to an estimated 22% drop from the previous closing price. Investors who purchased shares of Lufax between April 7, 2023, and January 26, 2025, and subsequently incurred losses, may qualify to seek compensation through the potential class action lawsuit.

Details of the Allegations

The complaint emphasizes the following key points regarding Lufax's operations and disclosures:

• - Inadequate Internal Controls: Lufax is accused of falsely certifying that internal controls were effective even when they were not, misleading investors considerably.
• - Undisclosed Related Party Transactions: The company purportedly failed to identify and disclose important transactions that could significantly affect investors’ decision-making.
• - Financial Misstatements: Major discrepancies in financial reporting were noted, including an overstated total income for 2022 by RMB 493.8 million, alongside expenses adjustments totaling RMB 473.5 million, resulting in a net profit exaggeration of RMB 917.0 million. For the following year, similar issues were alleged, with a net profit overstating amounting to RMB 81.4 million.

These purported inaccuracies were reportedly known or disregarded by Lufax’s management, raising significant concerns about accountability and transparency within the organization. Moreover, PwC, the firm responsible for auditing Lufax, ultimately withdrew its opinions pertaining to those financial years, suggesting a breakdown of trust in management's assertions.

The Implications of Generic Risk Disclosures

One major issue raised in the lawsuit is the lack of specificity in Lufax's risk disclosures. While the company lacked transparency about existing problems, its statements indicated that certain risks might emerge in the future. This distinction is crucial because it affects how investors perceive the company’s stability and governance integrity. Investors relied on filed reports that painted an optimistic picture of Lufax's operational health, which the lawsuit claims was, in fact, a misrepresentation.

Joseph E. Levi, Esq., a representative involved in the investigation, asserts that generic risk language cannot replace the necessity for specific disclosures about issues that are evidently impacting a company's operations. The complaint argues that investors were misled at a time when internal controls were already inadequate, casting doubt on the veracity of Lufax's financial health.

Next Steps for Affected Investors

As the deadline for potential lead plaintiff motions approaches on May 20, 2026, affected investors are urged to participate in the class action to pursue recovery for their losses. Lawyers representing the potential class action are seeking to hold Lufax accountable for its alleged mismanagement and failure to provide accurate disclosures.

Investors who wish to join the recovery action or get more information regarding their legal rights can contact Joseph E. Levi, Esq. at (888) SueWallSt.

In summary, the unfolding situation with Lufax Holding Ltd highlights significant concerns regarding investor protections and the imperative for transparency in financial disclosures. As the case develops, the outcomes may set important precedents for securities fraud litigation in the future.